-+ 0.00%
-+ 0.00%
-+ 0.00%
Can-Fite's Phase II Lowe Syndrome Trial Is Under Review in Italy
Share
Listen to the news
Can-Fite's Phase II Lowe Syndrome Trial Is Under Review in Italy
  • Italian health authorities are reviewing a proposed Phase II trial of Can-Fite's piclidenoson for Lowe syndrome.
  • The trial would evaluate efficacy and safety in five adults receiving oral treatment twice daily for six months.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Can Fite Biofpharma Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611120700PRIMZONEFULLFEED9876241) on November 12, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending